In response to proposed tariff hikes that could potentially double import taxes on pharmaceuticals, industry experts provide strategic guidance for pharmaceutical marketing executives. These recommendations focus on navigating volatility, ensuring supply chain resilience, and maintaining market competitiveness amid policy uncertainties. Preparing for tariff fluctuations is critical for sustaining drug availability and commercial success in a shifting regulatory environment.